coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Oldham South PCN, Oldham (LAD) · Health Inequalities Profile

    PCN U67660 · NHS Greater Manchester Integrated Care Board · 5 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    44,636

    Registered population

    61.7% aged 18–64

    13.8%

    Aged 65+

    ICB 14.9% · England 17.9%

    65.6%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~29,987

    Core20 residents (est.)

    Resident basis; registered basis ~29,058 · see page 3

    6,108

    Hypertension register

    +2.14% in 3 yrs · England +5.60%

    482

    SMI register

    16.6% of Oldham (LAD)'s

    1,219

    COPD register

    Reviews +2.41% in 3 yrs

    Forecast to 2030

    6,749

    Hypertension patients, 2030

    +641 on today

    85.0%

    QRISK ≥20% on statins, 2030

    +5.02pp over 3 yrs

    3.5%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    64.5%
    Hypertension treatment to target trails England.

    Control is 64.5% (England 70.3%) and recent BP recording is 84.9% (England 90.0%), which may reflect recall or titration gaps; audit registers.

    6.3 pp
    Age-five MMR2 drops below first dose.

    Age-5 MMR2 is 86.1% against 92.4% for MMR1 (4-in-1 booster 81.6% vs 95.0% target), which may reflect recall gaps; audit practice lists.

    73.8%
    Lipid therapy for high QRISK leads benchmarks.

    73.8% of patients with QRISK ≥ 20% receive lipid-lowering therapy (England 63.6%; Oldham 72.4%), alongside 79.6% of CKD patients (England 70.3%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Children aged 0-17 represent 24.5% of the PCN list compared with 19.6% across England

    Across 44,636 registered patients, 24.5% (10,939) are aged 0-17, matching Oldham (LAD) (24.6%) but above NHS Greater Manchester ICB (21.8%) and England (19.6%). Conversely, 13.8% (6,171) are aged 65+, compared to 13.2% in Oldham (LAD), 14.9% in the ICB, and 17.9% nationally. Patients aged 0-17 reach 30.9% at Hill Top Surgery and 29.2% at Oldham Medical Services, compared to 19.8% at Quayside Medical Practice. Roma residents comprise 0.5% (Oldham (LAD) 0.2%, ICB 0.1%, England 0.2%). Registered age counts and resident Census ethnicity use different bases, and observation periods are unstated.

    Age profile

    0–1724.5%
    18–6461.7%
    65+13.8%

    65+: ICB 14.9%, England 17.9%

    Older people · falls rows are Oldham (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Oldham LA)2,1412,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)87.1%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)57.8%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Oldham LA)1,1151,0219552024/25
    Falls deaths, all ages, per 100,000 (Oldham LA)20.918.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation covers 65.6% of patients but spans 62.7 pp across practices

    At 65.6%, the PCN Core20 share exceeds Oldham (LAD) (56.7%), the ICB (40.7%) and England (21.0%), with an average IMD decile of 2.7 (Oldham (LAD) 3.6, ICB 4.5, England 5.5). Weighted practice share (65.1%) shows a 0.54 pp reconciliation gap with the PCN rate. Practice concentration spans 62.7 pp, from 100.0% at Hill Top Surgery and 97.5% at Oldham Medical Services to 37.3% at Quayside Medical Practice. Hollinwood Medical Practice has an estimated 7,777 Core20 patients, while Quayside Medical Practice has an estimated 5,850.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Hill Top100.0% · 6,603 patients
    Oldham Medical97.5% · 5,756 patients
    Hollinwood86.5% · 7,777 patients
    Medlock Medical41.2% · 3,072 patients
    Quayside Medical37.3% · 5,850 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    482

    SMI register

    1.10% recorded prevalence

    325

    Learning disability register

    0.74% recorded prevalence

    12

    Care homes, 406 beds

    In the PCN catchment

    9.8%

    Provide unpaid care

    Oldham (LAD), Census 2021

    The PCN records 482 severe mental illness patients (1.1%; Oldham (LAD) 1.1%, NHS Greater Manchester ICB 1.1%, England 1.0%) and 325 on the learning disability register (0.7%; Oldham (LAD) 0.7%, ICB 0.6%, England 0.6%). Catchment services include 12 care homes with 406 beds, though bed capacity does not establish registered occupancy.

    Severe mental illness: physical health checks

    SMI prevalence is 1.1% (482 patients). Recorded blood pressure checks reached 86.8% (England 83.4%) and BMI recording was 89.0% (England 82.1%). Practice blood pressure checks range from 74.8% at Quayside Medical Practice to 97.7% at Oldham Medical Services.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,108

    Hypertension register

    +2.14%

    Register growth, 3 yrs

    Oldham (LAD) +4.38% · England +5.60%

    −2.32pp

    BP control, under 80

    ≤140/90 · −3.39pp aged 80+

    +641

    More patients by 2030

    Forecast 6,749 (14.49%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 13.9% (6,108 patients), below Oldham (LAD) (14.7%), NHS Greater Manchester Integrated Care Board (14.4%) and England (15.2%), giving a modelled register gap of +445 to +690 patients. Recent blood pressure reading coverage is 84.9% (England 90.0%). Treatment to target is 64.5% (England 70.3%), falling 1.1% over 2023 to 2025 while England rose +3.6%. Only 57.8% of patients aged under 80 (England 67.8%) and 70.0% aged 80+ (England 81.2%) achieve target control. Crude prevalence gaps are unadjusted for the PCN's younger population. Lower control leaves hypertensive patients under-protected against cardiovascular events, making structured recall and titration key priorities.

    Lipids and statins

    Lipid therapy coverage is high: 73.8% of patients with QRISK ≥ 20% receive lipid-lowering therapy, exceeding Oldham (LAD) (72.4%), NHS Greater Manchester Integrated Care Board (67.0%) and England (63.6%). Statin therapy reaches 79.6% in CKD (England 70.3%) and 79.5% in diabetes aged 40+ without CVD (England 73.2%). High treatment rates indicate strong primary prevention coverage.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202685,391£2.10£1.94£1.86£179,321
    Cardiovascular (all), 2025106,553£3.65£3.15£3.33£388,918

    In 2026, 85,391 items of lipid-regulating drugs cost £2.10 per item, exceeding Oldham (LAD) (£1.53), NHS Greater Manchester Integrated Care Board (£1.94) and England (£1.86). Across these items, the PCN spends £20,494 more than at England's unit cost. Unit costs above benchmark levels could reflect drug choices rather than prescribing inefficiency; local formulary reviews would test this.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +10.02%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −6.39%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 2.8% (1,219 patients; England 1.9%, Oldham (LAD) 2.3%) with a 78.4% review rate (England 76.4%). Asthma prevalence is 7.3% (2,986 patients; England 6.6%), and asthma reviews reached 73.1% (England 65.7%), leaving about 800 patients unreviewed. Paediatric asthma prescribing is 1,810 rate per 1,000 aged 5-19 (England 1,488; Oldham (LAD) 1,594). Elevated prevalence alongside high prescribing highlights the operational priority of focusing annual reviews on the 802 unreviewed patients.

    Cancer register and children's immunisation

    Cancer prevalence is 3.0% (1,306 patients; England 3.8%). In Q1 2025/26, 6-in-1 coverage at 12 months was 91.6% (England 91.0%). At age 5, MMR dose 1 reached 92.4% (England 91.7%), but MMR dose 2 was 86.1% (8.9 pp below the 95.0% target, 6.3 pp below dose 1) and the 4-in-1 booster was 81.6% (13.4 pp below target).

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months91.6%

    England 91.0%

    6-in-1 complete primary course at 24 months91.7%

    England 92.2%

    MMR dose 1 at 24 months90.2%

    England 88.3%

    MMR dose 2 at age 586.1%

    England 82.8%

    4-in-1 pre-school booster at age 581.6%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    Oldham South PCN records 3.0% crude cancer prevalence (1,306 patients; England 3.8%), while cervical screening reaches 73.9% (England 66.8%) and breast screening 69.4% after a 3-year rise of +17.2% (England +8.4%). Across the wider system, NHS Greater Manchester ICB recorded 55.6% of known-stage cancers diagnosed at stage 1 or 2 in 2022 (England 55.3%), sitting 19.4 pp below the 75.0% national ambition by 2028. Staging coverage was 70.8% (11,679 staged of 16,492 cases), leaving a gap of about 2,270 extra early cases annually. These ICB data describe system staging rather than PCN performance. Maintaining high screening coverage and safety-netting remains essential while system partners address diagnostic delays.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026, Manchester University NHS Foundation Trust achieved 72.8% on the 62-day cancer standard against the 85.0% standard, trailing Northern Care Alliance NHS Foundation Trust (78.6%), Tameside and Glossop Integrated Care NHS Foundation Trust (76.8%), and NHS Greater Manchester Integrated Care Board (75.7%), though above England (71.2%). On the 28-day faster diagnosis standard, the trust reached 80.1% (standard 75.0%; ICB 79.5%, England 79.3%). Trust diagnostic 6+ week waits were 14.7% for Computed Tomography and 11.7% for Magnetic Resonance Imaging. Acute provider delays could lengthen treatment times for referred patients, underscoring the importance of robust primary care safety-netting.

    Pathways within standard (%)ManchesterNorthern Care AllianceTameside and Glossop Integrated CareGreater Manchester ICBEngland
    28-day faster diagnosis (75%)80.0675.2082.4879.5379.32
    31-day treatment (96%)92.5494.5496.2596.4992.50
    62-day referral to treatment (85%)72.8578.6576.7775.7371.16
    Diagnostic waits over 6 weeks (%)ManchesterNorthern Care AllianceTameside and Glossop Integrated CareEngland
    MRI11.685.090.0021.40
    CT14.664.100.189.92
    Echocardiography4.9131.480.0028.48
    Colonoscopy4.5140.041.5130.83
    Gastroscopy29.3536.485.4529.02
    All 15 DM01 tests8.9815.710.8023.14
    Community services activityOldham residentsGreater Manchester ICB
    Care contacts71,440573,310
    Referrals8,26094,470
    Patients with a contact17,500183,535

    Community services (residents of Oldham), Jun 2026 (provisional). In June 2026, provisional community services data recorded 71,440 community contacts for Oldham residents. Contacts with adults aged 65 and over totalled 35,720, representing 50% of borough resident activity. With 50% of community contacts concentrated in older adults, community services offer key opportunities to coordinate supportive care across cancer and chronic pathways.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access ease spans 33.5 pp and overall patient experience spans 16.5 pp

    In 2025/26, QOF overall achievement ranged from 78.7% at Quayside Medical Practice to 92.3% at Hill Top Surgery (England 92.5%). Vaccination and immunisation achievement trailed national levels at all practices, spanning 30.3 pp from 15.6% at Medlock Medical Practice to 45.9% at Quayside Medical Practice (England 55.2%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Hill Top Surgery92100.050.4%81.1%81.8%
    Hollinwood12486.570.2%80.0%81.7%
    Oldham Medical12097.560.1%75.9%79.1%
    Medlock Medical10841.254.4%69.9%75.3%
    Quayside Medical10037.336.7%61.4%65.3%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNOldham (LAD)AssetPCNOldham (LAD)
    Care homes (catchment)12 (406 beds)n/aSchools (catchment)59n/a
    Children's centres416Places of worship37127
    Libraries510Primary schools (LA maintained)1242
    Primary academies941Special schoolsn/a1

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Pre-school booster and MMR2 recall

    In Q1 2025/26 (cohort 158), age-5 MMR1 is 92.4%, but MMR2 is 86.1% (6.3 pp below MMR1; 8.9 pp below the 95.0% target) and 4-in-1 booster is 81.6% (13.4 pp below). Moderate effort to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Option 2

    Hypertension control and case-finding audit

    Hypertension prevalence is 13.9% (6,108 of 44,636; Oldham (LAD) 14.7%, England 15.2%; unadjusted gap +445 to +690). Control is 64.5% (England 70.3%) and 57.8% under 80 (change -3.9% vs England +3.2%). For discussion: run pharmacist-led titration recall for patients above target and opportunistic BP checks across member practices. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 3

    Asthma annual review and prescribing check

    Asthma prevalence is 7.3% (2,986 patients; England 6.6%) and 73.1% had an annual review (Oldham (LAD) 72.7%, England 65.7%), leaving an estimated 802 patients unreviewed. For discussion: run a single-template recall for the estimated 802 unreviewed patients, pairing inhaler prescribing checks with after-school review slots. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Paediatric access coordination (p2)Aged 0-17Medium Term Planning Framework 2026 · Neighbourhood health frameworkPCN
    Two-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical health recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension recall and titration (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school immunisation call-recall outreach (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Screening coverage and safety netting (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Telephony and access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Pre-school booster and MMR2 recall (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 5 · 4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Option 2 · Hypertension control and case-finding audit (p12)Hypertension register · Hypertension: QOF prevalence · Hypertension patients with a recent BP readingCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 3 · Asthma annual review and prescribing check (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15